An Intelligent Graphene‐Based Biosensing Device for Cytokine Storm Syndrome Biomarkers Detection in Human Biofluids

Abstract Abnormal elevated levels of cytokines such as interferon (IFN), interleukin (IL), and tumor necrosis factor (TNF), are considered as one of the prognosis biomarkers for indicating the progression to severe or critical COVID‐19. Hence, it is of great significance to develop devices for monitoring their levels in COVID‐19 patients, and thus enabling detecting COVID‐19 patients that are worsening and to treat them before they become critically ill. Here, an intelligent aptameric dual channel graphene‐TWEEN 80 field effect transistor (DGTFET) biosensing device for on‐site detection of IFN‐γ, TNF‐α, and IL‐6 within 7 min with limits of detection (LODs) of 476 × 10 −15 , 608 × 10 −15 , or 611 × 10 −15 m respectively in biofluids is presented. Using the customized Android App together with this intelligent device, asymptomatic or mild COVID‐19 patients can have a preliminary self‐detection of cytokines and get a warning reminder while the condition starts to deteriorate. Also, the device can be fabricated on flexible substrates toward wearable applications for moderate or even critical COVID‐19 cases for consistently monitoring cytokines under different deformations. Hence, the intelligent aptameric DGTFET biosensing device is promising to be used for point‐of‐care applications for monitoring conditions of COVID‐19 patients who are in different situations.